Aerin Medical Inc.
“LASIK for the nose” to improve nasal breathing
This article was originally published in Start Up
Executive Summary
Aerin Medical Inc.’s new procedure, called InFlux, could replace an invasive surgery with a 15-minute in-office procedure to help patients who complain of poor nasal breathing, and also serve people who simply want to breathe better.
You may also be interested in...
ENT Devices: Large Markets, Minimally Invasive Procedures Fuel Innovation
For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.